MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II

Hariyadarshi Pannu, Van Tran-Fadulu, Christina L. Papke, Steve Scherer, Yaozhong Liu, Caroline Presley, Dongchuan Guo, Anthony L. Estrera, Hazim J. Safi, Allan R. Brasier, G. Wesley Vick, A. J. Marian, C. S. Raman, L. Maximilian Buja, Dianna M. Milewicz

Research output: Contribution to journalArticle

152 Citations (Scopus)

Abstract

Non-syndromic thoracic aortic aneurysms and dissections (TAADs) are inherited in an autosomal dominant manner in ∼20% of cases. Familial TAAD is genetically heterogeneous and four loci have been mapped for this disease to date, including a locus at 16p for TAAD associated with patent ductus arteriosus (PDA). The defective gene at the 16p locus has recently been identified as the smooth muscle cell (SMC)-specific myosin heavy chain gene (MYH11). On sequencing MYH11 in 93 families with TAAD alone and three families with TAAD/PDA, we identified novel mutations in two families with TAAD/PDA, but none in families with TAAD alone. Histopathological analysis of aortic sections from two individuals with MYH11 mutations revealed SMC disarray and focal hyperplasia of SMCs in the aortic media. SMC hyperplasia leading to significant lumen narrowing in some of the vessels of the adventitia was also observed. Insulin-like growth factor-1 (IGF-1) was upregulated in mutant aortas as well as explanted SMCs, but no increase in transforming growth factor-β expression or downstream targets was observed. Enhanced expression of angiotensin-converting enzyme and markers of Angiotensin II (Ang II) vascular inflammation (macrophage inflammatory protein-1α and β) were also found. These data suggest that MYH11 mutations are likely to be specific to the phenotype of TAAD/PDA and result in a distinct aortic and occlusive vascular pathology potentially driven by IGF-1 and Ang II.

Original languageEnglish (US)
Pages (from-to)2453-2462
Number of pages10
JournalHuman Molecular Genetics
Volume16
Issue number20
DOIs
StatePublished - Oct 15 2007

Fingerprint

Thoracic Aortic Aneurysm
Insulin-Like Growth Factor II
Angiotensin II
Blood Vessels
Dissection
Pathology
Patent Ductus Arteriosus
Mutation
Smooth Muscle Myocytes
Hyperplasia
Macrophage Inflammatory Proteins
Adventitia
Myosin Heavy Chains
Transforming Growth Factors
Somatomedins
Peptidyl-Dipeptidase A
Genes
Aorta
Inflammation
Phenotype

ASJC Scopus subject areas

  • Genetics

Cite this

Pannu, H., Tran-Fadulu, V., Papke, C. L., Scherer, S., Liu, Y., Presley, C., ... Milewicz, D. M. (2007). MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II. Human Molecular Genetics, 16(20), 2453-2462. https://doi.org/10.1093/hmg/ddm201

MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II. / Pannu, Hariyadarshi; Tran-Fadulu, Van; Papke, Christina L.; Scherer, Steve; Liu, Yaozhong; Presley, Caroline; Guo, Dongchuan; Estrera, Anthony L.; Safi, Hazim J.; Brasier, Allan R.; Vick, G. Wesley; Marian, A. J.; Raman, C. S.; Buja, L. Maximilian; Milewicz, Dianna M.

In: Human Molecular Genetics, Vol. 16, No. 20, 15.10.2007, p. 2453-2462.

Research output: Contribution to journalArticle

Pannu, H, Tran-Fadulu, V, Papke, CL, Scherer, S, Liu, Y, Presley, C, Guo, D, Estrera, AL, Safi, HJ, Brasier, AR, Vick, GW, Marian, AJ, Raman, CS, Buja, LM & Milewicz, DM 2007, 'MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II', Human Molecular Genetics, vol. 16, no. 20, pp. 2453-2462. https://doi.org/10.1093/hmg/ddm201
Pannu, Hariyadarshi ; Tran-Fadulu, Van ; Papke, Christina L. ; Scherer, Steve ; Liu, Yaozhong ; Presley, Caroline ; Guo, Dongchuan ; Estrera, Anthony L. ; Safi, Hazim J. ; Brasier, Allan R. ; Vick, G. Wesley ; Marian, A. J. ; Raman, C. S. ; Buja, L. Maximilian ; Milewicz, Dianna M. / MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II. In: Human Molecular Genetics. 2007 ; Vol. 16, No. 20. pp. 2453-2462.
@article{d583088ebc3e460bb1bf937b706fa0a9,
title = "MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II",
abstract = "Non-syndromic thoracic aortic aneurysms and dissections (TAADs) are inherited in an autosomal dominant manner in ∼20{\%} of cases. Familial TAAD is genetically heterogeneous and four loci have been mapped for this disease to date, including a locus at 16p for TAAD associated with patent ductus arteriosus (PDA). The defective gene at the 16p locus has recently been identified as the smooth muscle cell (SMC)-specific myosin heavy chain gene (MYH11). On sequencing MYH11 in 93 families with TAAD alone and three families with TAAD/PDA, we identified novel mutations in two families with TAAD/PDA, but none in families with TAAD alone. Histopathological analysis of aortic sections from two individuals with MYH11 mutations revealed SMC disarray and focal hyperplasia of SMCs in the aortic media. SMC hyperplasia leading to significant lumen narrowing in some of the vessels of the adventitia was also observed. Insulin-like growth factor-1 (IGF-1) was upregulated in mutant aortas as well as explanted SMCs, but no increase in transforming growth factor-β expression or downstream targets was observed. Enhanced expression of angiotensin-converting enzyme and markers of Angiotensin II (Ang II) vascular inflammation (macrophage inflammatory protein-1α and β) were also found. These data suggest that MYH11 mutations are likely to be specific to the phenotype of TAAD/PDA and result in a distinct aortic and occlusive vascular pathology potentially driven by IGF-1 and Ang II.",
author = "Hariyadarshi Pannu and Van Tran-Fadulu and Papke, {Christina L.} and Steve Scherer and Yaozhong Liu and Caroline Presley and Dongchuan Guo and Estrera, {Anthony L.} and Safi, {Hazim J.} and Brasier, {Allan R.} and Vick, {G. Wesley} and Marian, {A. J.} and Raman, {C. S.} and Buja, {L. Maximilian} and Milewicz, {Dianna M.}",
year = "2007",
month = "10",
day = "15",
doi = "10.1093/hmg/ddm201",
language = "English (US)",
volume = "16",
pages = "2453--2462",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "20",

}

TY - JOUR

T1 - MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II

AU - Pannu, Hariyadarshi

AU - Tran-Fadulu, Van

AU - Papke, Christina L.

AU - Scherer, Steve

AU - Liu, Yaozhong

AU - Presley, Caroline

AU - Guo, Dongchuan

AU - Estrera, Anthony L.

AU - Safi, Hazim J.

AU - Brasier, Allan R.

AU - Vick, G. Wesley

AU - Marian, A. J.

AU - Raman, C. S.

AU - Buja, L. Maximilian

AU - Milewicz, Dianna M.

PY - 2007/10/15

Y1 - 2007/10/15

N2 - Non-syndromic thoracic aortic aneurysms and dissections (TAADs) are inherited in an autosomal dominant manner in ∼20% of cases. Familial TAAD is genetically heterogeneous and four loci have been mapped for this disease to date, including a locus at 16p for TAAD associated with patent ductus arteriosus (PDA). The defective gene at the 16p locus has recently been identified as the smooth muscle cell (SMC)-specific myosin heavy chain gene (MYH11). On sequencing MYH11 in 93 families with TAAD alone and three families with TAAD/PDA, we identified novel mutations in two families with TAAD/PDA, but none in families with TAAD alone. Histopathological analysis of aortic sections from two individuals with MYH11 mutations revealed SMC disarray and focal hyperplasia of SMCs in the aortic media. SMC hyperplasia leading to significant lumen narrowing in some of the vessels of the adventitia was also observed. Insulin-like growth factor-1 (IGF-1) was upregulated in mutant aortas as well as explanted SMCs, but no increase in transforming growth factor-β expression or downstream targets was observed. Enhanced expression of angiotensin-converting enzyme and markers of Angiotensin II (Ang II) vascular inflammation (macrophage inflammatory protein-1α and β) were also found. These data suggest that MYH11 mutations are likely to be specific to the phenotype of TAAD/PDA and result in a distinct aortic and occlusive vascular pathology potentially driven by IGF-1 and Ang II.

AB - Non-syndromic thoracic aortic aneurysms and dissections (TAADs) are inherited in an autosomal dominant manner in ∼20% of cases. Familial TAAD is genetically heterogeneous and four loci have been mapped for this disease to date, including a locus at 16p for TAAD associated with patent ductus arteriosus (PDA). The defective gene at the 16p locus has recently been identified as the smooth muscle cell (SMC)-specific myosin heavy chain gene (MYH11). On sequencing MYH11 in 93 families with TAAD alone and three families with TAAD/PDA, we identified novel mutations in two families with TAAD/PDA, but none in families with TAAD alone. Histopathological analysis of aortic sections from two individuals with MYH11 mutations revealed SMC disarray and focal hyperplasia of SMCs in the aortic media. SMC hyperplasia leading to significant lumen narrowing in some of the vessels of the adventitia was also observed. Insulin-like growth factor-1 (IGF-1) was upregulated in mutant aortas as well as explanted SMCs, but no increase in transforming growth factor-β expression or downstream targets was observed. Enhanced expression of angiotensin-converting enzyme and markers of Angiotensin II (Ang II) vascular inflammation (macrophage inflammatory protein-1α and β) were also found. These data suggest that MYH11 mutations are likely to be specific to the phenotype of TAAD/PDA and result in a distinct aortic and occlusive vascular pathology potentially driven by IGF-1 and Ang II.

UR - http://www.scopus.com/inward/record.url?scp=34848825045&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34848825045&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddm201

DO - 10.1093/hmg/ddm201

M3 - Article

C2 - 17666408

AN - SCOPUS:34848825045

VL - 16

SP - 2453

EP - 2462

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 20

ER -